Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 12Burkitt Lymphoma 8Lymphoma, Follicular 7Sarcoma 5Lymphoma, Non-Hodgkin 5Hodgkin Disease 5Neoplasms 4Lymphoma 4Wilms Tumor 3Sarcoma, Ewing 3Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 3Osteosarcoma 3Lymphoma, B-Cell 3Liposarcoma 3Endometrial Neoplasms 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Plasmablastic Lymphoma 2Ovarian Neoplasms 2Multiple Myeloma 2Lymphoproliferative Disorders 2Lymphoma, T-Cell 2Lymphoma, Mantle-Cell 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leiomyosarcoma 2Histiocytoma, Malignant Fibrous 2Ganglioneuroblastoma 2Fallopian Tube Neoplasms 2Down Syndrome 2Dermatofibrosarcoma 2

Interventions

liposomal doxorubicin 1Zidovudine 1Vincristine 1Valganciclovir 1Sirolimus 1Rituximab 1Prednisone 1Interferon-alpha 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Etoposide 1Doxorubicin 1Cyclophosphamide 1Bortezomib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphadenopathy × Doxorubicin × 30 days × Clear all
NCT00092222 2026-06-05

Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity

National Institutes of Health Clinical Center (CC)

Phase 2 Active not recruiting
75 enrolled
Lymphoid

Multi-centric Castleman's Disease, Macular dystrophy, corneal type 1, Lymphadenopathy, Lymphoproliferative Disorders, Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡